Blanket Purchase Agreement 36F79719D0247-36E79724A0006
Award Date 2/27/24
Last Date to Order 9/25/25
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- The Blanket Purchase Agreement (BPA) is a federal contract indefinite delivery vehicle (IDV) awarded by the National Acquisition Center, a civilian agency within the Department of Veterans Affairs (VA), to Genzyme Corporation, doing business as Sanofi Genzyme. The BPA has a ceiling value of $3,000,000 and a period of performance from June 6, 2024 to June 5, 2026. The purpose of the BPA is to provide the VA with a streamlined contracting method to procure specialty pharmaceutical products,...
- The Blanket Purchase Agreement was awarded by the Department of Veterans Affairs National Acquisition Center to Ucb, Inc. for the procurement of pharmaceutical products. Specifically, the BPA covers Cimzia, Nayzilam, Neupro, Vimpat, Briviact, and Keppra for a potential value of $609,090,892.65. The contract was awarded on October 20, 2022 and has a performance period through the last date to order of November 14, 2022. No set-aside provisions were applied to this single-award BPA. The BPA was...
- The Blanket Purchase Agreement (BPA) is a federal contract indefinite delivery vehicle (IDV) awarded by the Department of Veterans Affairs' National Acquisition Center to Bayer Healthcare Pharmaceuticals Inc., a subsidiary of the global pharmaceutical company Bayer AG. The $6,788,810.45 single-award BPA is for the procurement of Xofigo (radium Ra 223 dichloride) and Adempas (riociguat), specialized pharmaceutical products used to treat prostate cancer and pulmonary arterial hypertension,...
- This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center, a civilian federal agency, to Actelion Pharmaceuticals US, Inc., a large pharmaceutical manufacturer. The BPA has a ceiling value of $118,500,000 and a period of performance from August 2024 to August 2026, with an option year extending it to August 2027. The BPA is for the procurement of specialized pharmaceutical products, primarily focused on medications for the treatment of rare diseases and pulmonary...
- This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center, a civilian federal agency, to Acer Therapeutics Inc. The contract has a ceiling value of $1,891,583.25 and a period of performance through July 7, 2026. The BPA is for the procurement of MIPLYFFA and OLPRUVA, two pharmaceutical products. No set-asides were used, and this was a single-award contract. The contract vehicle is based on the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) managed by the...
- The Blanket Purchase Agreement (BPA) is a single-award contract issued by the Office of Administration and Resource Management (OARM), a civilian agency within the federal government. The prime contractor, Award Company of America, LLC, is a self-certified small disadvantaged business located in Tuscaloosa, Alabama. The BPA has a ceiling value of $500,000 and a period of performance through April 15, 2029. The primary products and services being delivered under this BPA include the design,...
- The Blanket Purchase Agreement (BPA) is an indefinite delivery vehicle (IDV) awarded by a U.S. federal government agency to Supplycore Inc., a prime contractor. The BPA is under the Hardware Superstore Federal Supply Schedule (FSS-51-V), a General Services Administration (GSA) multiple-award schedule contract. The BPA, with a potential value of $9,000,000.00, aims to provide a range of routine consumable and administrative products to support federal government operations. This includes office...
- The Blanket Purchase Agreement (BPA) is a multiple award indefinite delivery vehicle (IDV) awarded by the Defense Finance and Accounting Service (DFAS), a defense agency, to Document Imaging Dimensions Inc., a for-profit vendor located in Yorkville, Illinois. The BPA has a ceiling value of $496,000.00 and a period of performance from April 3, 2017, to April 2, 2022. It is described as a "COPY PAPER MASTER AGREEMENT" and is primarily focused on providing a wide range of office...
- The Blanket Purchase Agreement was awarded by the Department of Veterans Affairs National Acquisition Center to Viela Bio, Inc. for the pharmaceutical Uplizna. With a potential value of $4,348,680, the single award BPA has a period of performance through May 5, 2022 and was awarded on January 12, 2021. The BPA was established against the Pharmaceuticals and Drugs GSA schedule to provide Uplizna, which is indicated for the treatment of neuromyelitis optica spectrum disorder in adult patients...
- This Blanket Purchase Agreement (BPA) contract was awarded by the National Acquisition Center, a civilian federal agency, to Merz Pharmaceuticals, LLC, a for-profit foreign-owned organization. The BPA is established under the GSA Federal Supply Schedule 61-IB for Pharmaceuticals and Drugs, with a ceiling value of $12,057,300.00 and a period of performance running through March 12, 2026. The purpose of this BPA is to provide the agency with the pharmaceutical products Ampyra and Inbrijia. No...